2012•Journal of HepatologyRequires access

1006 WHY IS RADIOFREQUENCY ABLATION THERAPY (RFA) APPLIED FOR HEPATOCELLULAR CARCINOMA (HCC) UP TO 3 NODULES AND SMALLER THAN 3 CM IN TUMOR SIZE?

Genryu Hirano, Keiji Yokoyama, Daisuke Morihara, Yoshihumi Takeyama, Masato Sakamoto, M Irie, K. Iwata, Satoshi Shakado, Tetsuro Sohda, Shotaro Sakisaka

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Hepatocellular carcinoma, Radiofrequency ablation, Medicine, Ablation, Ablation Therapy, Tumor ablation, Radiology, Oncology

Back to paper search Browse research topics Original source

1006 WHY IS RADIOFREQUENCY ABLATION THERAPY (RFA) APPLIED FOR HEPATOCELLULAR CARCINOMA (HCC) UP TO 3 NODULES AND SMALLER THAN 3 CM IN TUMOR SIZE? — Research Paper | ScholarLens